J&J Pulls Power Morcellators from the Market, Asks Docs to Return All Devices
Johnson & Johnson has issued “a worldwide market withdrawal” of all power morcellator devices that remained on the market after a sale suspension in April, the Washington Post reports.
The company said on July 30th that it planned to ask doctors the next day to return power morcellators they bought prior to April, when a suspension of Ethicon morcellator sales and distribution was announced. Johnson & Johnson’s action was prompted by a federal warning from the U.S. Food and Drug Administration (FDA) that advised doctors against using them in certain gynecologic surgeries, pending further review from the agency.
According to the FDA alert on April 17th, 2014, one in every 350 women undergoing fibroid removals may have undetected uterine sarcoma or another type of cancer prior to surgery that may be spread by a power morcellator. This may severely diminish a woman’s chances of long-term survival, as this type of cancer is aggressive, and may be life-threatening.
Power morcellators are used in minimally-invasive laparoscopic hysterectomy and fibroid removal surgeries to more easily cut up uterine tissue so it can be extracted via a tiny incision. According to morcellator lawsuits though, the spinning blades on morcellators may promote the spread of malignant tumors into the abdominal cavity.
J&J Decision Follows Advisory Panel Meeting on Power Morcellator Surgery
Johnson & Johnson’s decision to remove these products from the market follows a two-day meeting of the FDA’s Obstetrics and Gynecology Devices Panel that took place earlier this month. Panelists remained divided on whether to remove power morcellators from market after the meeting on July 10th and 11th, however, after some insisted that patients benefit from their use. According to a Boston Globe report, women whose uterine cancer allegedly spread because of a power morcellator spoke at the meeting, where they delivered heartfelt testimonies they hoped would influence panelists into banning this type of surgery.
On July 22nd, a study published by the Journal of the American Medical Association underlined uterine morcellation concerns after finding that 1 in 368 women having fibroids removed may have undiagnosed cancer in their uterus.
The research also showed that 32 percent of patients with undiagnosed uterine cancer were younger than 50.
Pursue a Power Morcellator Lawsuit
As power morcellator lawsuits continue to be filed on behalf of women whose life-threatening uterine cancer was allegedly spread because of the device, the time is now to file a claim of your own. Call our Firm directly at (877) 779-1414.